Novavax, Inc. (NVAX)
NASDAQ: NVAX · Real-Time Price · USD
6.00
-0.20 (-3.23%)
At close: Apr 17, 2025, 4:00 PM
6.00
0.00 (0.00%)
After-hours: Apr 17, 2025, 5:14 PM EDT
Novavax Employees
Novavax had 952 employees as of December 31, 2024. The number of employees decreased by 591 or -38.30% compared to the previous year.
Employees
952
Change (1Y)
-591
Growth (1Y)
-38.30%
Revenue / Employee
$716,557
Profits / Employee
-$196,953
Market Cap
965.07M
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novartis AG | 75,883 |
NVAX News
- 5 days ago - SHIELD-Utah Study Shows Novavax's COVID-19 Vaccine Induces Lower Reactogenicity Symptoms Compared to mRNA - PRNewsWire
- 9 days ago - Novavax shares tumble after U.S. health secretary raises concerns over COVID shot's efficacy - Reuters
- 17 days ago - The FDA was moving to grant full approval for Novavax's Covid-19 vaccine. But it missed the April 1 deadline after the agency's vaccine chief was forced out. - WSJ
- 17 days ago - FDA misses deadline for decision on Novavax's COVID-19 vaccine, WSJ reports - Reuters
- 19 days ago - Vaccine stocks tumble: Moderna, Novavax, Pfizer fall after top FDA official resigns over RFK Jr. anti-vax views - Fast Company
- 19 days ago - Drug stocks sink as FDA's top vaccine official is ousted in Trump overhaul - New York Post
- 19 days ago - Vaccine stocks fall after key FDA official resigns in protest of RFK Jr. - CNBC
- 20 days ago - Biotech stocks tumble on reports FDA's top vaccine regulator to leave - Reuters